European Loan Funds F2G's Late-Stage Novel Antifungal

 
• By Eleanor Malone

€24m loan from the European Investment Bank with match funding will progress Phase IIb antifungal Olorofim in invasive aspergillosis. CFO Ralf Schmid goes into details with Scrip.

Tulips
New human antifungals needed as tulip fungicides increase drug resistance • Source: Shutterstock

More from Financing

More from Business